Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy

HR Keir, JD Chalmers - European Respiratory Review, 2022 - Eur Respiratory Soc
Neutrophilic inflammation has a key role in the pathophysiology of multiple chronic lung
diseases. The formation of neutrophil extracellular traps (NETs) has emerged as a key …

[HTML][HTML] The microbiome in bronchiectasis

H Richardson, AJ Dicker, H Barclay… - European Respiratory …, 2019 - Eur Respiratory Soc
Bronchiectasis is increasing in prevalence worldwide, yet current treatments available are
limited to those alleviating symptoms and reducing exacerbations. The pathogenesis of the …

Proteome profiling of recombinant DNase therapy in reducing NETs and aiding recovery in COVID-19 patients

J Fisher, T Mohanty, CAQ Karlsson… - Molecular & Cellular …, 2021 - ASBMB
Severe coronavirus disease 2019 (COVID-19) can result in pneumonia and acute
respiratory failure. Accumulation of mucus in the airways is a hallmark of the disease and …

Mucus structure, viscoelastic properties, and composition in chronic respiratory diseases

M Abrami, A Biasin, F Tescione, D Tierno… - International Journal of …, 2024 - mdpi.com
The respiratory mucus, a viscoelastic gel, effectuates a primary line of the airway defense
when operated by the mucociliary clearance. In chronic respiratory diseases (CRDs), such …

Proteomic analysis of human sputum for the diagnosis of lung disorders: where are we today?

M D'Amato, P Iadarola, S Viglio - International Journal of Molecular …, 2022 - mdpi.com
The identification of markers of inflammatory activity at the early stages of pulmonary
diseases which share common characteristics that prevent their clear differentiation is of …

[HTML][HTML] Diminished airway host innate response in people with cystic fibrosis who experience frequent pulmonary exacerbations

CJ Houston, A Alkhatib, GG Einarsson… - European …, 2024 - Eur Respiratory Soc
Rationale Pulmonary exacerbations are clinically impactful events that accelerate cystic
fibrosis (CF) lung disease progression. The pathophysiological mechanisms underlying an …

Metaproteomics to decipher CF host-microbiota interactions: overview, challenges and future perspectives

P Hardouin, R Chiron, H Marchandin, J Armengaud… - Genes, 2021 - mdpi.com
Cystic fibrosis (CF) is a hereditary disease caused by mutations in the CF transmembrane
conductance regulator (CFTR) gene, triggering dysfunction of the anion channel in several …

[HTML][HTML] The relationship between lung disease severity and the sputum proteome in cystic fibrosis

RE Maher, E Barrett, RJ Beynon, VM Harman… - Respiratory …, 2022 - Elsevier
Background Proteomics can reveal molecular pathways of disease and provide translational
perspectives to inform clinical decision making. Although several studies have previously …

[HTML][HTML] What diagnostic tests are available for respiratory infections or pulmonary exacerbations in cystic fibrosis: A scoping literature review

R Naseem, N Howe, CJ Williams, S Pretorius… - Respiratory …, 2024 - Elsevier
A scoping review methodological framework formed the basis of this review. A search of two
electronic databases captured relevant literature published from 2013. 1184 articles were …

[HTML][HTML] Quick and wide-range taxonomical repertoire establishment of the cystic fibrosis lung microbiota by tandem mass spectrometry on sputum samples

P Hardouin, O Pible, H Marchandin… - Frontiers in …, 2022 - frontiersin.org
Microorganisms proteotyping by tandem mass spectrometry has been recently shown as a
powerful methodology to identify the wide-range taxonomy and biomass of microbiota …